Literature DB >> 4000483

Survival in Alzheimer's disease and vascular dementias.

L L Barclay, A Zemcov, J P Blass, J Sansone.   

Abstract

Over 5 years, we followed 199 patients with dementia of the Alzheimer type (DAT), 69 with multi-infarct dementia (MID), and 43 with mixed dementia (MIX). All three diagnostic categories had comparable progression of behavioral and cognitive impairment and need for home care or institutionalization at follow-up. However, 50% survival from diagnosis was 2.6 years for MID and 2.5 years for MIX, compared with 3.4 years for DAT. The 50% survivals from onset were longer than previous reports would suggest (8.1 years for DAT, 6.7 for MID, and 6.2 for MIX). Vascular dementias have higher mortality than DAT, even when associated with comparable cognitive and behavioral impairment.

Entities:  

Mesh:

Year:  1985        PMID: 4000483     DOI: 10.1212/wnl.35.6.834

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Predictors of mortality in patients with Alzheimer's disease living in nursing homes.

Authors:  G Gambassi; F Landi; K L Lapane; A Sgadari; V Mor; R Bernabei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Alzheimer's disease as a cause of death in the United States.

Authors:  D L Hoyert; H M Rosenberg
Journal:  Public Health Rep       Date:  1997 Nov-Dec       Impact factor: 2.792

3.  Dementia in old age.

Authors:  A Haines; C Katona
Journal:  Occas Pap R Coll Gen Pract       Date:  1992-12

Review 4.  [Whats new on dementia?].

Authors:  S Riu-Subirana; J L Rodríguez-Cubas
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

5.  Relation between cognitive impairment and early death in the elderly.

Authors:  J M Eagles; J A Beattie; D B Restall; F Rawlinson; S Hagen; G W Ashcroft
Journal:  BMJ       Date:  1990-01-27

6.  Neuropathological assessment of the lesions of significance in vascular dementia.

Authors:  M M Esiri; G K Wilcock; J H Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

7.  Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Authors:  K Rockwood; J Mintzer; L Truyen; T Wessel; D Wilkinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

8.  Deaths attributable to Alzheimer's disease in the United States.

Authors:  D C Ewbank
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

9.  Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.

Authors:  Xingbin Wang; Oscar Lopez; Robert A Sweet; James T Becker; Steven T DeKosky; Mahmud M Barmada; Eleanor Feingold; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

10.  [Impact of vascular pathology on survival times of 173 dementia patients--Hachinski's ischemic score as a predictive tool for clinical purposes].

Authors:  S Kissler; S D Hötte; D Lankers; G Juckel; S G Schröder
Journal:  Z Gerontol Geriatr       Date:  2008-02       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.